Mitchell McLeod Pugh & Williams’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $814K | Buy |
7,867
+8
| +0.1% | +$714 | 0.1% | 166 |
|
|
2026
Q1 | $564K | Sell |
7,859
-1,880
| -19% | -$145K | 0.08% | 179 |
|
|
2025
Q4 | $763K | Buy |
9,739
+397
| +4% | +$31.3K | 0.11% | 153 |
|
|
2025
Q3 | $768K | Buy |
9,342
+1,345
| +17% | +$92.2K | 0.12% | 141 |
|
|
2025
Q2 | $552K | Buy |
7,997
+9
| +0.1% | +$590 | 0.1% | 165 |
|
|
2025
Q1 | $541K | Buy |
7,988
+11
| +0.1% | +$658 | 0.11% | 167 |
|
|
2024
Q4 | $358K | Sell |
7,977
-193
| -2% | -$10.8K | 0.08% | 200 |
|
|
2024
Q3 | $514K | Hold |
8,170
| – | – | 0.11% | 172 |
|
|
2024
Q2 | $483K | Hold |
8,170
| – | – | 0.11% | 165 |
|
|
2024
Q1 | $652K | Hold |
8,170
| – | – | 0.16% | 145 |
|
|
2023
Q4 | $645K | Sell |
8,170
-15
| -0.2% | -$1.07K | 0.17% | 138 |
|
|
2023
Q3 | $572K | Buy |
8,185
+1,369
| +20% | +$97K | 0.17% | 137 |
|
|
2023
Q2 | $471K | Sell |
6,816
-1,170
| -15% | -$83.2K | 0.14% | 153 |
|
|
2023
Q1 | $593K | Sell |
7,986
-86
| -1% | -$7.21K | 0.18% | 129 |
|
|
2022
Q4 | $752K | Hold |
8,072
| – | – | 0.25% | 112 |
|
|
2022
Q3 | $770K | Buy |
8,072
+18
| +0.2% | +$1.78K | 0.3% | 96 |
|
|
2022
Q2 | $747K | Sell |
8,054
-215
| -3% | -$21K | 0.29% | 98 |
|
|
2022
Q1 | $837K | Sell |
8,269
-772
| -9% | -$81.1K | 0.28% | 97 |
|
|
2021
Q4 | $932K | Hold |
9,041
| – | – | 0.31% | 95 |
|
|
2021
Q3 | $767K | Hold |
9,041
| – | – | 0.28% | 104 |
|
|
2021
Q2 | $754K | Sell |
9,041
-100
| -1% | -$8.19K | 0.29% | 107 |
|
|
2021
Q1 | $688K | Buy |
9,141
+271
| +3% | +$19.7K | 0.29% | 106 |
|
|
2020
Q4 | $606K | Hold |
8,870
| – | – | 0.28% | 110 |
|
|
2020
Q3 | $518K | Buy |
8,870
+887
| +11% | +$55.2K | 0.27% | 116 |
|
|
2020
Q2 | $519K | Buy |
7,983
+2
| +0% | +$126 | 0.3% | 107 |
|
|
2020
Q1 | $474K | Hold |
7,981
| – | – | 0.37% | 96 |
|
|
2019
Q4 | $593K | Sell |
7,981
-161
| -2% | -$11.3K | 0.37% | 95 |
|
|
2019
Q3 | $514K | Buy |
8,142
+79
| +1% | +$4.68K | 0.35% | 104 |
|
|
2019
Q2 | $439K | Buy |
8,063
+950
| +13% | +$51.2K | 0.3% | 114 |
|
|
2019
Q1 | $383K | Buy |
7,113
+160
| +2% | +$9.88K | 0.27% | 129 |
|
|
2018
Q4 | $456K | Buy |
6,953
+670
| +11% | +$50K | 0.37% | 99 |
|
|
2018
Q3 | $495K | Sell |
6,283
-450
| -7% | -$32.2K | 0.33% | 110 |
|
|
2018
Q2 | $433K | Hold |
6,733
| – | – | 0.31% | 119 |
|
|
2018
Q1 | $419K | Buy |
6,733
+450
| +7% | +$32.3K | 0.3% | 123 |
|
|
2017
Q4 | $455K | Hold |
6,283
| – | – | 0.31% | 112 |
|
|
2017
Q3 | $511K | Hold |
6,283
| – | – | 0.38% | 99 |
|
|
2017
Q2 | $505K | Buy |
6,283
+1
| +0% | +$79 | 0.38% | 97 |
|
|
2017
Q1 | $493K | Buy |
6,282
+1
| +0% | +$80 | 0.39% | 94 |
|
|
2016
Q4 | $496K | Buy |
6,281
+1
| +0% | +$81 | 0.4% | 86 |
|
|
2016
Q3 | $558K | Buy |
6,280
+1
| +0% | +$94 | 0.49% | 75 |
|
|
2016
Q2 | $601K | Buy |
6,279
+200
| +3% | +$19.9K | 0.54% | 67 |
|
|
2016
Q1 | $630K | Sell |
6,079
-100
| -2% | -$9.72K | 0.61% | 60 |
|
|
2015
Q4 | $604K | Hold |
6,179
| – | – | 0.6% | 61 |
|
|
2015
Q3 | $596K | Sell |
6,179
-250
| -4% | -$26.3K | 0.62% | 59 |
|
|
2015
Q2 | $675K | Hold |
6,429
| – | – | 0.62% | 54 |
|
|
2015
Q1 | $663K | Buy |
6,429
+52
| +0.8% | +$5.26K | 0.6% | 58 |
|
|
2014
Q4 | $614K | Buy |
+6,377
| New | +$562K | 0.57% | 62 |
|
Other funds holding CVS
Mitchell McLeod Pugh & Williams's CVS Position: Q2 2026 in Review
Mitchell McLeod Pugh & Williams increased its CVS Health (CVS) stake by 0.1% in Q2 2026, buying an estimated $714 and bringing the position to 7,867 shares worth $814K. The position accounts for 0.1% of the portfolio, ranked #166.
Mitchell McLeod Pugh & Williams first reported a position in CVS in Q4 2014 and has held it in 47 quarters since. The position peaked at $932K in Q4 2021. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Mitchell McLeod Pugh & Williams held 7,867 shares of CVS Health worth $814K as of Q2 2026.
- Mitchell McLeod Pugh & Williams bought 8 CVS Health shares in Q2 2026, an estimated $714.
- CVS Health made up 0.1% of Mitchell McLeod Pugh & Williams's portfolio in Q2 2026, its #166 holding.
- Mitchell McLeod Pugh & Williams first reported a position in CVS Health in Q4 2014 and has held it in 47 quarters since.
- Mitchell McLeod Pugh & Williams's CVS Health position peaked at $932K in Q4 2021.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Mitchell McLeod Pugh & Williams's 13F filing for Q2 2026, filed 11 Aug 2026.